Aristotle University of Thessaloniki-ko ikertzaileekin lankidetzan egindako argitalpenak (3)

2020

  1. Exploring sodium glucose co-transporter-2 (SGLT2) inhibitors for organ protection in COVID-19

    Journal of Clinical Medicine, Vol. 9, Núm. 7, pp. 1-16

2019

  1. SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA

    Nephrology Dialysis Transplantation, Vol. 34, Núm. 2, pp. 208-230

2017

  1. Redefining Cut-Points for High Symptom Burden of the Global Initiative for Chronic Obstructive Lung Disease Classification in 18,577 Patients With Chronic Obstructive Pulmonary Disease

    Journal of the American Medical Directors Association, Vol. 18, Núm. 12, pp. 1097.e11-1097.e24